Fred Hutch Prepares for Inaugural Bike Ride to Accelerate Lifesaving Cancer Research
Jan 14, 2013 (Close-Up Media via COMTEX) --
Driven by the goal to end cancer, Obliteride is a new, community-wide experience which will accelerate lifesaving research at Fred Hutchinson Cancer Research Center.
According to a release, Obliteride is an entire weekend of cycling, celebrations and concerts. Registration opens at Obliteride.org for the inaugural fundraising bike ride scheduled for Aug. 9-11, 2013. The ride will include multiple routes in Western Washington, offering various distances and terrains so all levels of riders can make their marks against cancer.
"Obliteride is so much more than a phenomenal bike ride," said Amy Lavin, Obliteride executive director. "It's a movement of people committed to obliterating cancer and saving lives faster. Our goal is to ensure the event is fully underwritten so 100 percent of every dollar raised goes directly to lifesaving cancer research right here in Seattle."
Obliteride is not your average bike-a-thon. It is going to be big, because cancer is BIG. The goal for the inaugural year is to net $2.5 million and engage 2,500 riders and 1,000 volunteers.
As a nonprofit organization, Fred Hutch relies on funding from the government, individuals, businesses and foundations to fund these discoveries and eradicate cancer. Federal funding for cancer research has flat lined in recent years, yet the incidence of cancer keeps growing. This makes the need for philanthropic support from our community more urgent than ever.
Driven by the goal to end cancer, Obliteride is a new, community-wide experience to raise money to accelerate lifesaving research at Fred Hutchinson Cancer Research Center.
((Comments on this story may be sent to firstname.lastname@example.org))
[ Back To TMCnet.com's Homepage ]